Skip to main content
. 2019 Nov 29;11(12):637. doi: 10.3390/pharmaceutics11120637

Figure 5.

Figure 5

Temporal concentrations of drug with different hyperthermia schedules. (a) Free drug concentration in systemic plasma, (b) drug concentration in intracellular space at r = 0 µm, (c) average and peak drug concentration in systemic plasma and (d) average and peak topotecan concentration in intracellular space at r = 0 µm.